Trends in underlying causes of death in allogeneic hematopoietic cell transplant recipients over the last decade.

Andreas SøborgJoanne ReekieHenrik SengeløvCaspar Da Cunha-BangThomas Kromann LundChristina EkenbergIsabelle Paula LoddingKasper Sommerlund MoestrupLouise LundgrenJens D LundgrenNeval Ete Wareham

Published in: European journal of haematology (2024)

As risk of all-cause mortality and death from GvHD decreases, death from relapse remains the greatest obstacle in further improvement of survival after HCT.

Keyphrases

cell proliferation
bone marrow
pi k akt
single cell
cell therapy
stem cells
low dose
mesenchymal stem cells
cell cycle arrest
hematopoietic stem cell